Furthermore, HNO itself can limit •O2− production by directly inhibiting vascular NADPH oxidase (Nox2) (Miller et al., 2009), supporting our results that endogenous generation and/or bioavailability of HNO is preserved in the large conduit artery in this model of diabetes. Here, FMO5 is linked to diabetes mellitus.